# Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

> **NCT07400926** · — · RECRUITING · sponsor: **Glaukos Corporation** · enrollment: 30 (estimated)

## Conditions studied

- Open Angle Glaucoma (OAG)
- Ocular Hypertension (OH)

## Interventions

- **COMBINATION_PRODUCT:** Travoprost

## Key facts

- **NCT ID:** NCT07400926
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-17
- **Primary completion:** 2026-06
- **Final completion:** 2026-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07400926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07400926, "Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07400926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*